Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1Unknown 1Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 4Gastrointestinal 4Thoracic 3Sarcoma 3Plasma cell 2Gynecologic 2Genitourinary 2Breast 2Other neoplasm 1Myeloid 1Lymphoid 1Head & Neck 1Dermatologic 1

Conditions

Myelodysplastic Syndromes 92Leukemia, Myelogenous, Chronic, BCR-ABL Positive 82Leukemia, Myeloid, Acute 79Leukemia 41Myeloproliferative Disorders 34Precursor Cell Lymphoblastic Leukemia-Lymphoma 30Multiple Myeloma 21Leukemia, Myeloid, Chronic-Phase 20Lymphoma, Non-Hodgkin 18Lymphoma 18Leukemia, Lymphocytic, Chronic, B-Cell 17Leukemia, Myelomonocytic, Chronic 16Polycythemia Vera 14Hodgkin Disease 14Primary Myelofibrosis 11Lymphoma, Large B-Cell, Diffuse 11Neoplasms, Plasma Cell 10Lymphoma, Follicular 10Hematologic Neoplasms 10Burkitt Lymphoma 10Recurrence 9Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 9Anemia, Refractory, with Excess of Blasts 9Myelodysplastic-Myeloproliferative Diseases 8Mastocytosis, Systemic 8Mastocytosis 8Lymphoma, Mantle-Cell 8Lymphoma, Large-Cell, Immunoblastic 8Lymphoma, B-Cell, Marginal Zone 8Leukemia, Myeloid, Accelerated Phase 8

Interventions

sargramostim 1Cyclophosphamide 1Carboplatin 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Drug-Related Side Effects and Adverse Reactions × Myeloid × Clear all
NCT00004036 2013-12-19

Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer

National Cancer Institute (NCI)

Phase 1 Unknown
30 enrolled
LymphoidMyeloidOther hematologic neoplasmOther neoplasmPlasma cell

Immunoglobulin Light-chain Amyloidosis, Blast Crisis, Burkitt Lymphoma, Hodgkin Disease, Immunoblastic Lymphadenopathy, Leukemia, Leukemia, Hairy Cell, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Polycythemia Vera, Precancerous Conditions, Thrombocythemia, Essential, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Prolymphocytic, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Leukemia, Large Granular Lymphocytic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Primary Myelofibrosis, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡